Tumor suppressor gene TP53 is genetically associated with schizophrenia in the Chinese population
Neuroscience Letters, ISSN: 0304-3940, Vol: 369, Issue: 2, Page: 126-131
2004
- 28Citations
- 31Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations28
- Citation Indexes28
- 28
- CrossRef25
- Captures31
- Readers31
- 31
Article Description
Schizophrenia is a debilitating mental disorder. The TP53 tumor suppressor gene, encoding a phosphoprotein, is a key element in maintaining genomic stability and cell apoptosis. Recently, reduced risk of cancer in patients of schizophrenia has been reported. Some evidence also suggests the possible implication of TP53 in neurodevelopment. In order to examine the role of the TP53 gene in the pathogenesis of schizophrenic disorders, we investigated the genetic association between a functional polymorphism rs1042522 and schizophrenia by sequencing the fragment covering 72Pro> Arg in 701 cases and 695 controls in this work. In addition, we studied two other SNPs rs2078486 and rs8064946 by allele-specific PCR in the same samples. Though rs1042522 and rs8064946 did not show positive association with schizophrenia, we did observe statistically significant differences on SNP rs2078486 ( P -value = 0.029; OR = 1.21; 95% CI 1.02–1.42) and on haplotype CAC ( P -value = 0.0068; OR = 1.36; 95% CI 1.09–1.70). These results demonstrated that TP53 might play a role in susceptibility to schizophrenia.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S0304394004009280; http://dx.doi.org/10.1016/j.neulet.2004.07.068; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=4644341668&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/15450681; https://linkinghub.elsevier.com/retrieve/pii/S0304394004009280; https://dx.doi.org/10.1016/j.neulet.2004.07.068
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know